BWAY logo

BrainsWay Ltd. Stock Price

TASE:BWAY Community·₪1.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

BWAY Share Price Performance

₪28.22
10.32 (57.65%)
₪28.22
10.32 (57.65%)
Price ₪28.22

BWAY Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with high growth potential.

0 Risks
3 Rewards

BrainsWay Ltd. Key Details

US$49.1m

Revenue

US$12.3m

Cost of Revenue

US$36.8m

Gross Profit

US$30.5m

Other Expenses

US$6.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.16
74.92%
12.73%
0%
View Full Analysis

About BWAY

Founded
2003
Employees
120
CEO
Hadar Levy
WebsiteView website
www.brainsway.com

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Recent BWAY News & Updates

Recent updates

No updates